Cara Bailey
Physician Assistant · Delco, NCNPI 1124406509
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,693 of the $25,892 with a category attached, or 72.2%. It is spread thinly across 32 manufacturers, the largest accounting for just 18.8%. Reporting peaked in 2022 at $7,981 and has fallen 52.6% since, to $3,781 in 2025. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 889 payments — averaging $29.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$5K
- Amgen$4K
- Johnson & Johnson$3K
- AbbVie$3K
- UCB, Inc.$2K
- Pfizer$1K
- plus $8K from 26 others
What the payments were for
- Consulting fees$6,22324%
- Travel & lodging$5102%
- Food & beverage$18,69372%
- Education$4652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 10 | $4,855 |
| Amgen(2 entities) | 159 | $3,713 |
| Johnson & Johnson(3 entities) | 93 | $3,377 |
| AbbVie | 122 | $2,656 |
| UCB, Inc. | 67 | $2,274 |
| Pfizer | 109 | $1,377 |
| Novartis | 50 | $1,230 |
| Lilly USA, LLC | 42 | $966 |
| GSK | 41 | $862 |
| AstraZeneca(2 entities) | 29 | $760 |
| Radius Health, Inc. | 27 | $564 |
| Organon | 23 | $542 |
| Boehringer Ingelheim | 18 | $454 |
| Sanofi | 13 | $409 |
| Fresenius Kabi USA, LLC | 17 | $351 |
| Mallinckrodt Hospital Products Inc. | 16 | $331 |
| E.r. Squibb & Sons, L.L.C. | 7 | $157 |
| Sanofi-aventis U.S. LLC | 2 | $155 |
| Genentech USA, Inc. | 8 | $135 |
| Aurinia Pharma U.S., Inc. | 7 | $127 |
| ANI Pharmaceuticals, Inc. | 5 | $110 |
| Sandoz | 5 | $93 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $91 |
| Almatica Pharma LLC | 4 | $86 |
| Sobi, Inc | 3 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $44 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| Invivyd Inc | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,892 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 33 | $256,774 |
| Humira(Cf) PenAdalimumab | 17 | $193,112 |
| Humira(Cf)Adalimumab | 23 | $163,374 |
| RinvoqUpadacitinib | 19 | $119,778 |
| OtezlaApremilast | 20 | $114,554 |
| Enbrel MiniEtanercept | 14 | $102,206 |
| Xeljanz XrTofacitinib Citrate | 16 | $92,427 |
| Orencia ClickjectAbatacept | 13 | $72,558 |
| TymlosAbaloparatide | 15 | $39,733 |
| Hydroxychloroquine Sulfate | 227 | $10,219 |
| MethotrexateMethotrexate Sodium | 304 | $7,735 |
| MitigareColchicine | 17 | $7,461 |
| Colchicine | 62 | $4,735 |
| Leflunomide | 85 | $4,425 |
| Celecoxib | 72 | $3,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf), Rinvoq | $2,656 | $283,15242 claims |
| AmgenOtezla | $3,713 | $114,55420 claims |
| Radius Health, Inc.Tymlos | $564 | $39,73315 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $23 | $4,73562 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Delco
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.